News from the medical world

 

September 2019

Umbrella review of the efficacy of nutritional supplements and dietary interventions - Sun, 09/01/2019 - 16:30

August 2019

Dear Doctor letter: Avoid concomitant use of fluoroquinolones and ACEI/ARBs - Fri, 08/02/2019 - 11:30
Is the Advertising Regulatory Board too lenient? - Fri, 08/02/2019 - 11:30

June 2019

Contraceptives and the risk of HIV infection - Sun, 06/30/2019 - 10:30
Topical vitiligo treatment - Sun, 06/30/2019 - 10:30
Bedaquiline ADRs: published by one of our pharmacists - Mon, 06/24/2019 - 11:45

May 2019

A reminder for retail pharmacists - Wed, 05/01/2019 - 09:15
Managing antimicrobial resistance in SA hospitals - Wed, 05/01/2019 - 09:15

April 2019

Hydrochlorothiazide and the risk of skin cancer - Mon, 04/01/2019 - 09:00
Esketamine for depression - Mon, 04/01/2019 - 09:00
NEJM’s Question of the Week - Mon, 04/01/2019 - 08:45

March 2019

Malaria: Limpopo officials issue a warning - Mon, 03/04/2019 - 12:45
SAHPRA weighs in on quinolone concerns - Mon, 03/04/2019 - 12:30
New ways of managing hypertension - Mon, 03/04/2019 - 12:30

January 2019

Vaccine hesitancy: A global health threat according to the WHO - Thu, 01/31/2019 - 12:45
IV Artesunate for treatment of severe malaria in children and adults - Thu, 01/31/2019 - 12:30
Interim RR-TB clinical guidelines error: children’s dosing incorrect - Wed, 01/02/2019 - 11:30
Revolutionising cancer diagnosis using nano-signatures - Wed, 01/02/2019 - 11:30
Newly updated NDoH Standard Treatment Guidelines: - Wed, 01/02/2019 - 11:15

December 2018

Fingertip units for steroids - Tue, 12/04/2018 - 09:45
Further curbs on quinolones - Tue, 12/04/2018 - 09:45

October 2018

Is herpes simplex causing Alzheimer’s? - Thu, 10/25/2018 - 10:00
Adulterants in dietary supplements: FDA warning - Thu, 10/25/2018 - 10:00
Ritonavir boosting in children on lopinavir/ritonavir (LPV/r) and rifampicin - Tue, 10/09/2018 - 17:15
Ketamine clinics - Tue, 10/09/2018 - 17:00

September 2018

TST no longer needed prior to INH prophylaxis (IPT): National DOH Circular - Tue, 09/04/2018 - 10:15
New FDA safety announcement for SGLT2 inhibitors - Tue, 09/04/2018 - 10:15
Good news for open access journal articles - Tue, 09/04/2018 - 10:15

August 2018

New malaria treatment - Wed, 08/01/2018 - 11:00
Some valsartan products recalled - Wed, 08/01/2018 - 10:45

June 2018

Dolutegravir in pregnancy: A no-no - Fri, 06/01/2018 - 16:15
Lamotrigine new adverse reaction - Fri, 06/01/2018 - 16:15

May 2018

Herd immunity benefits vs. individual risks - Tue, 05/01/2018 - 09:45
Safe and affordable hepatitis C treatment - Tue, 05/01/2018 - 09:45
Happy Birthday to Us! The National HIV & TB Health Care Worker Hotline is 10! - Tue, 05/01/2018 - 09:45

March 2018

Reducing some antipsychotic doses may actually improve schizophrenia symptoms - Wed, 03/28/2018 - 20:45
Induction phase for cryptococcal meningitis treatment - Wed, 03/28/2018 - 20:45
We need your help - Wed, 03/28/2018 - 20:30
Dolutegravir-rifapentine PK study stopped early - Sun, 03/04/2018 - 09:15
The burden of medication errors in the NHS in England - Sun, 03/04/2018 - 09:15
Useful malaria information - Sun, 03/04/2018 - 09:15

February 2018

Steroids for septic shock - Thu, 02/01/2018 - 16:00
Third dose of MMR - Thu, 02/01/2018 - 16:00
Concerns about energy drinks - Thu, 02/01/2018 - 15:45

November 2017

Benzodiazepines and mortality risk in Alzheimer’s disease - Wed, 11/29/2017 - 16:30
Diclofenac inferior to antibiotics for symptomatic relief of UTIs - Wed, 11/29/2017 - 16:30
New Tool: Management of suspected drug-induced rash, kidney injury and liver injury in adult patients on TB treatment and/or antiretroviral treatment - Wed, 11/29/2017 - 16:15

October 2017

Reminder: Valproate and pregnancy - Tue, 10/31/2017 - 10:45
Applying for third line antiretroviral (ARV) therapy - Tue, 10/31/2017 - 10:45
Updated malaria treatment guidelines - Tue, 10/03/2017 - 09:45